Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 825-829
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.825
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.825
Table 1 Clinicopathologic characteristics of patients with HCC and APS
| Characteristics | Ethanol group(n = 64) | Gelfoam group(n = 33) | P value |
| Age (y) | 56.4 ± 21.4 | 52.3 ± 26.6 | 0.42 |
| Sex (M/F) | 52/12 | 25/7 | 0.72 |
| Child classification | |||
| Child class A | 35(55%) | 20(61%) | |
| Child class B | 29(45%) | 13(39%) | 0.56 |
| Serum total bilirubin (mg/ml) | 1.6 ± 1.5 | 2.0 ± 1.8 | 0.31 |
| Serum albumin (g/dl) | 3.6 ± 0.8 | 3.4 ± 1.1 | 0.30 |
| Number of tumors | |||
| 1 | 15(23%) | 11(33%) | |
| 2~3 | 19(30%) | 8(24%) | |
| 4, diffuse | 30(47%) | 14(43%) | 0.32 |
- Citation: Huang MS, Lin Q, Jiang ZB, Zhu KS, Guan SH, Li ZR, Shan H. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(6): 825-829
- URL: https://www.wjgnet.com/1007-9327/full/v10/i6/825.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i6.825